PATHWAY TO CURES (P2C) IS FOCUSED ON FILLING THE FUNDING GAP AND INVESTING IN THE DEVELOPMENT OF TRANSFORMATIONAL THERAPIES AND TECHNOLOGIES FOR ALL INHERITABLE BLOOD AND BLEEDING DISORDERS.
P2C takes a focused investment approach, investing only in companies that offer the potential to change the lives of those living with inheritable blood and bleeding disorders.
HOW WE INVEST
An experienced team including, investment professionals, scientific researchers, and volunteers working towards a singular mission.
WHO WE ARE
